Showing 1 - 10 of 203
Persistent link: https://www.econbiz.de/10012519380
, operations and results. Moreover, regional distribution of the selected projects was evaluated. Data from MCT, FINEP, Innovation …
Persistent link: https://www.econbiz.de/10010330888
Two major changes in Brazilian legislation during the 1990s reshaped the local pharmaceutical industry: the ratification of the TRIPS agreement including a provision for pipeline inventions in 1996, and a Generic Drug Act in 1999, which introduced bioequivalence tests and facilitated generic...
Persistent link: https://www.econbiz.de/10010330912
aging and urbanizing population. The government has also set the health industry - which includes pharmaceutical innovation … improvement to be made in the area of matching innovation to the epidemiological needs of Brazilian population. This paper reviews … the international literature on mechanism design to bring incentives to pharmaceutical innovation without compromising …
Persistent link: https://www.econbiz.de/10010330928
This paper tries to build and to analyze the evolution of technological indexes in Brazilian chemical industry during the 1985-2009 period. Our main conclusions are the following: the petrochemical emphasis of this industry has stood by; besides there have been an important technological...
Persistent link: https://www.econbiz.de/10011444834
The Covid-19 pandemic exposed the fragility of institutional supply arrangements to the world and sparked predatory competition among buyers. In this context, the rationalization of demand and use of medical inputs and the centralized management o these acquisitions are recommended strategies,...
Persistent link: https://www.econbiz.de/10012616474
The text discusses possibilities of public policies for the development of biopharmaceuticals in Brazil, with emphasis on monoclonal antibodies (mAbs). First section discusses the basic concepts about biotechnology, biopharmaceuticals and monoclonal antibodies in order to sustain the later...
Persistent link: https://www.econbiz.de/10012146729
Two major changes in Brazilian legislation during the 1990s reshaped the local pharmaceutical industry: the ratification of the TRIPS agreement including a provision for pipeline inventions in 1996, and a Generic Drug Act in 1999, which introduced bioequivalence tests and facilitated generic...
Persistent link: https://www.econbiz.de/10008729423
This paper tries to build and to analyze the evolution of technological indexes in Brazilian chemical industry during the 1985-2009 period. Our main conclusions are the following: the petrochemical emphasis of this industry has stood by; besides there have been an important technological...
Persistent link: https://www.econbiz.de/10011389965